Evidence map›Paper›PMID 36835810›Full record

ArticleJournal of clinical medicine2023

Hospital Readmission Risk and Risk Factors of People with a Primary or Secondary Discharge Diagnosis of Diabetes.

Daniel J Rubin, Naveen Maliakkal, Huaqing Zhao, Eli E Miller

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel J RubinSection of Endocrinology, Diabetes, and Metabolism, Lewis Katz School of Medicine, Temple University, 3322 N. Broad Street, Suite 205, Philadelphia, PA 19140, USA.ORCID 0000-0002-6871-6246
Naveen MaliakkalDepartment of Medicine, Temple University Hospital, Philadelphia, PA 19140, USA.
Huaqing ZhaoDepartment of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, 3322 N. Broad Street, Suite 205, Philadelphia, PA 19140, USA.
Eli E MillerSection of Endocrinology, Diabetes, and Metabolism, Lewis Katz School of Medicine, Temple University, 3322 N. Broad Street, Suite 205, Philadelphia, PA 19140, USA.ORCID 0000-0001-7208-5494

Funding

Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetesR01DK122073 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI RUBIN, DANIEL J · 2020 to 2024
$2.8M
Predicting and Preventing Hospital Readmission in Patients with Diabetes and CVDK23DK102963 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI RUBIN, DANIEL J · 2015 to 2018
$713k
NIDDK NIH HHS K23 DK102963NIDDK NIH HHS R01 DK122073the National Institute of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health K23DK102963 and R01DK122073
6 · The paper itself

Abstract

Hospital readmission among people with diabetes is common and costly. A better understanding of the differences between people requiring hospitalization primarily for diabetes (primary discharge diagnosis, 1°DCDx) or another condition (secondary discharge diagnosis, 2°DCDx) may translate into more effective ways to prevent readmissions. This retrospective cohort study compared readmission risk and risk factors between 8054 hospitalized adults with a 1°DCDx or 2°DCDx. The primary outcome was all-cause hospital readmission within 30 days of discharge. The readmission rate was higher in patients with a 1°DCDx than in patients with a 2°DCDx (22.2% vs. 16.2%,

Indexed as

diabetesreadmissionrisk factors

Identifiers

PMID36835810
PMCPMC9961750

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.